A phase II randomised, double-blind, placebo-controlled, proof of concept study of oral seletalisib in patients with primary Sjögren’s syndrome (PSS).

Maria Juárez; Nieves Diaz; Geoffrey I Johnston; Saba Nayar; Andrew Payne; Eric Helmer; Dionne Cain; Paulette Williams; Wan Fai Ng; Benjamin Fisher; Jacques-Eric Gottenberg; Giuliana Guggino; Xavier Mariette; Marika Kvarnström; Valérie Devauchelle-Pensec; Jose Rosas; Juan Sanchez-Burson; Roberto Giacomelli; Francesca Barone; Simon J Bowman

Conference Papers Year : 2019

A phase II randomised, double-blind, placebo-controlled, proof of concept study of oral seletalisib in patients with primary Sjögren’s syndrome (PSS).

(1) , (1) , (1) , (2) , (1) , (1) , (1) , (3) , (4) , (2) , (5) , (6) , (7) , (8) , (9, 10) , (11) , (12) , (13) , (2) , (14)

1
2
3
4
5
6
7
8
9
10
11
12
13
14

Maria Juárez

Function : Author

UCB Pharma [Slough]

Nieves Diaz

Function : Author

UCB Pharma [Slough]

Geoffrey I Johnston

Function : Author

UCB Pharma [Slough]

Saba Nayar

Function : Author

University of Birmingham [Birmingham]

Andrew Payne

Function : Author

UCB Pharma [Slough]

Eric Helmer

Function : Author

UCB Pharma [Slough]

Dionne Cain

Function : Author

UCB Pharma [Slough]

Paulette Williams

Function : Author

UCB Pharma Raleigh

Wan Fai Ng

Function : Author

University of Newcastle, Newcastle upon Tyne, UK

Benjamin Fisher

Function : Author
PersonId : 782676
ORCID : 0000-0003-4631-549X

University of Birmingham [Birmingham]

Jacques-Eric Gottenberg

Function : Author
PersonId : 756827
ORCID : 0000-0002-9469-946X

Les Hôpitaux Universitaires de Strasbourg

Giuliana Guggino

Function : Author

Università degli studi di Palermo - University of Palermo

Xavier Mariette

Function : Author
PersonId : 756829
ORCID : 0000-0002-4244-5417
IdRef : 113094116

Service de rhumatologie

Marika Kvarnström

Function : Author

Unit of Experimental Rheumatology, Stockhom

Valérie Devauchelle-Pensec

Function : Author
PersonId : 766858
ORCID : 0000-0003-0432-825X

CHRU Brest - Service de Rhumatologie

Lymphocytes B, Autoimmunité et Immunothérapies

Jose Rosas

Function : Author

Hospital Marina Baixa, Villajoyosa

Juan Sanchez-Burson

Function : Author

Infantaluisa Hospital, Sevilla

Roberto Giacomelli

Function : Author

University of L'Aquila [Italy]

Francesca Barone

Function : Author
PersonId : 11410
IdHAL : francesca-barone
IdRef : 13162413X

University of Birmingham [Birmingham]

Simon J Bowman

Function : Author

University Hospital Birmingham

Domains

Immunology

Geneviève Michel : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-02150798

Submitted on : Friday, June 7, 2019-2:34:54 PM

Last modification on : Friday, November 29, 2024-3:39:27 PM

Dates and versions

hal-02150798 , version 1 (07-06-2019)

Identifiers

HAL Id : hal-02150798 , version 1

Cite

Maria Juárez, Nieves Diaz, Geoffrey I Johnston, Saba Nayar, Andrew Payne, et al.. A phase II randomised, double-blind, placebo-controlled, proof of concept study of oral seletalisib in patients with primary Sjögren’s syndrome (PSS).. EULAR 2019, Jun 2019, MADRID, Spain. ⟨hal-02150798⟩

A phase II randomised, double-blind, placebo-controlled, proof of concept study of oral seletalisib in patients with primary Sjögren’s syndrome (PSS).

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Share